These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29497113)

  • 21. Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.
    Holzmann C; Witt M; Rolfs A; Antipova V; Wree A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
    Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
    FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease.
    Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T
    Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-range action of an HDAC inhibitor treats chronic pain in a spared nerve injury rat model.
    Centeno MV; Alam MS; Haldar K; Apkarian AV
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease.
    Collins CJ; Loren BP; Alam MS; Mondjinou Y; Skulsky JL; Chaplain CR; Haldar K; Thompson DH
    Sci Rep; 2017 Apr; 7():46737. PubMed ID: 28452365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1.
    Calias P
    Curr Pharm Des; 2017; 23(40):6231-6238. PubMed ID: 29065825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder.
    Brown A; Patel S; Ward C; Lorenz A; Ortiz M; DuRoss A; Wieghardt F; Esch A; Otten EG; Heiser LM; Korolchuk VI; Sun C; Sarkar S; Sahay G
    Sci Rep; 2016 Aug; 6():31750. PubMed ID: 27572704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal gene repression in Niemann-Pick type C models is mediated by the c-Abl/HDAC2 signaling pathway.
    Contreras PS; Gonzalez-Zuñiga M; González-Hódar L; Yáñez MJ; Dulcey A; Marugan J; Seto E; Alvarez AR; Zanlungo S
    Biochim Biophys Acta; 2016 Feb; 1859(2):269-79. PubMed ID: 26603102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.
    Tamura A; Yui N
    J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease.
    Marshall CA; Borbon IA; Erickson RP
    J Appl Genet; 2017 Feb; 58(1):99-102. PubMed ID: 27783333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered localization and functionality of TAR DNA Binding Protein 43 (TDP-43) in niemann- pick disease type C.
    Dardis A; Zampieri S; Canterini S; Newell KL; Stuani C; Murrell JR; Ghetti B; Fiorenza MT; Bembi B; Buratti E
    Acta Neuropathol Commun; 2016 May; 4(1):52. PubMed ID: 27193329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adenosine A
    Ferrante A; Pezzola A; Matteucci A; Di Biase A; Attorri L; Armida M; Martire A; Chern Y; Popoli P
    Neurobiol Dis; 2018 Feb; 110():1-11. PubMed ID: 29079454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C.
    Yasmin N; Ishitsuka Y; Fukaura M; Yamada Y; Nakahara S; Ishii A; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Okada Y; Nishikawa J; Ichikawa A; Iohara D; Hirayama F; Higaki K; Ohno K; Matsuo M; Irie T
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity.
    Zhou Y; Takahashi S; Homma K; Duan C; Zheng J; Cheatham MA; Zheng J
    Acta Neuropathol Commun; 2018 Sep; 6(1):98. PubMed ID: 30249300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.
    Alam MS; Getz M; Yi S; Kurkewich J; Safeukui I; Haldar K
    J Biol Chem; 2014 Mar; 289(12):8051-66. PubMed ID: 24488491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NPC1 deficiency impairs cerebellar postnatal development of microglia and climbing fiber refinement in a mouse model of Niemann-Pick disease type C.
    Boyle BR; Melli SE; Altreche RS; Padron ZM; Yousufzai FAK; Kim S; Vasquez MD; Carone DM; Carone BR; Soto I
    Development; 2020 Aug; 147(21):. PubMed ID: 32611604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains.
    Causevic M; Dominko K; Malnar M; Vidatic L; Cermak S; Pigoni M; Kuhn PH; Colombo A; Havas D; Flunkert S; McDonald J; Gunnersen JM; Hutter-Paier B; Tahirovic S; Windisch M; Krainc D; Lichtenthaler SF; Hecimovic S
    PLoS One; 2018; 13(7):e0200344. PubMed ID: 29979789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and distribution of 2-hydroxypropyl-β-cyclodextrin following a single intrathecal dose to cats.
    Kao ML; Stellar S; Solon E; Lordi A; Kasica N; Swain G; Bagel JH; Gurda BL; Vite CH
    J Inherit Metab Dis; 2020 May; 43(3):618-634. PubMed ID: 31707730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice.
    Schlegel V; Thieme M; Holzmann C; Witt M; Grittner U; Rolfs A; Wree A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.
    Cawley NX; Sojka C; Cougnoux A; Lyons AT; Nicoli ER; Wassif CA; Porter FD
    PLoS One; 2020; 15(1):e0227829. PubMed ID: 31999726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.